Drugs: L

lomustine

Alkylating Activity [MoA]; Alkylating Drug [EPC]

0 identified pills

loperamide hydrochloride, simethicone

Opioid Agonist [EPC]; Opioid Agonists [MoA]; Skin Barrier Activity [PE]

0 identified pills

loratadine 5 mg chewable tablets

0 identified pills

loratadine and pseudoephedrine

Adrenergic alpha-Agonists [MoA]; alpha-Adrenergic Agonist [EPC]

0 identified pills

loratadine and pseudoephedrine sulfate

Adrenergic alpha-Agonists [MoA]; alpha-Adrenergic Agonist [EPC]

0 identified pills

loratadine tablet

0 identified pills

loratadine, Pseudoephedrine sulfate

Adrenergic alpha-Agonists [MoA]; alpha-Adrenergic Agonist [EPC]

0 identified pills

lorlatinib

Breast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 3A Inducers [MoA]; Kinase Inhibitor [EPC]; Kinase Inhibitors [MoA]; Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]; Organic Anion Transporter 3 Inhibitors [MoA]; Organic Cation Transporter 1 Inhibitors [MoA]; P-Glycoprotein Inducers [MoA]

0 identified pills

lumacaftor and ivacaftor

Chloride Channel Activation Potentiators [MoA]; Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC]; Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 2C19 Inducers [MoA]; Cytochrome P450 2C8 Inducers [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 2C9 Inducers [MoA]; Cytochrome P450 2C9 Inhibitors [MoA]; Cytochrome P450 3A Inducers [MoA]; Cytochrome P450 3A Inhibitors [MoA]; P-Glycoprotein Inducers [MoA]; P-Glycoprotein Inhibitors [MoA]

0 identified pills

lumateperone

Atypical Antipsychotic [EPC]

0 identified pills

lurasidone hydrochloride

Atypical Antipsychotic [EPC]

0 identified pills